TAUROPHARM
TauroPharm is a manufacturer of medicines for dialysis, oncology, and parenteral nutrition.
TAUROPHARM
Social Links:
Industry:
Health Care Hospital Medical Oncology
Founded:
1999-01-01
Address:
Waldbüttelbrunn, Bayern, Germany
Country:
Germany
Website Url:
http://www.taurolock.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Euro Ip.labs GmbH
Similar Organizations
Centre Hospitalier de Sens
Centre Hospitalier de Sens is a healthcare organization that offers maternity, pediatrics, obstetrics, oncology, and surgical services.
Oncolines B.V.
Oncolines B.V. is a precision medicine services company in oncology and cancer immunotherapy.
Pole Sante Oreliance
Pole Sante Oreliance is a healthcare institution that specializes in medical surgery, pediatric care, oncology, and general medicine.
Reinier de Graaf hospital
Reinier de Graaf hospital provides specialized and complex care for elderly, oncology and mother and child.
The Private Hospital of confluent
The Private Hospital of confluent is a healthcare firm that offers medical imaging, oncology, rehabilitation, and orthopedic services.
Val d'Yerres Private Hospital
Val d'Yerres Private Hospital is a health care centre that specializes in nephrology, oncology, and gastroenterology.
Official Site Inspections
http://www.taurolock.com Semrush global rank: 1.34 M Semrush visits lastest month: 19.66 K
- Host name: iridium.icue-medien.de
- IP address: 213.190.31.113
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "TauroPharm"
Antimicrobial lock solutions | TauroLock™
TauroLock™-HEP100. TauroLock™-HEP100 can be used for patients who previously relied on heparin-based lock solutions. Central-venous catheters remain infection-free and sustain a …See details»
About our company | TauroPharm
In 2000, TauroPharm GmbH was founded as a German company specialising in antimicrobial solutions.We have since developed a versatile product range: TauroLock™ for venous …See details»
TauroLock™ – about the product - TauroPharm
We recommend TauroLock™ for all vascular access devices (VADs) in parenteral nutrition, oncology, and – as an alternative to TauroLock™-HEP500 or TauroLock™-U25.000 – in …See details»
20 years TauroLock™: Interview with founder Claus Herdeis
Jul 4, 2024 Since then, the TauroLock™ 2+1 protocol has been our gold standard for dialysis: TauroLock™-HEP500 twice a week and TauroLock™-U25.000 once a week to effectively …See details»
TauroLock™ turns 20 | TauroPharm
TauroLock™ turns 20. 23 January 2024 2024 marks a milestone for TauroLock™ solutions: Our products have now been on the market for two decades. Locked lines save lives – 20 years …See details»
News | TauroLock™ - TauroPharm
Feb 20, 2023 TauroLock™ turns 20. In 2024, our products have now been on the market for two decades. Read more. 26 October 2023. A sticky matter: biofilm and catheter-related infections. …See details»
Solutions verrous - Théradial
La gamme de solutions verrous TauroLock™ est indiquée chez les patients porteurs d’un dispositif d’accès vasculaire veineux central (cathéters, chambres implantables, PICC-line, …See details»
About our lock solutions | TauroLock™ - TauroPharm
TauroLock™-HEP100. TauroLock™-HEP100 can be used for patients who previously relied on heparin-based lock solutions. Central-venous catheters remain infection-free and sustain a …See details»
Contact us via phone or email | TauroLock™ - TauroPharm
TauroLock™-HEP100. TauroLock™-HEP100 can be used for patients who previously relied on heparin-based lock solutions. Central-venous catheters remain infection-free and sustain a …See details»
Taurolidine-based catheter lock regimen significantly reduces …
The Charlson Comorbidity Index 36 and World Health Organization performance status 37 were documented for the study population. Exclusion criteria for study patients were as follows: age …See details»
tauroexpo
TauroLock™-HEP500 in Dialysis "The best solution down the line" Van Roeden. TauroLock™-HEP500 in Dialysis ensures superior dialysis quality and protects from infection and …See details»
4. NutriLock™ and TauroLock™ lock solutions? - Transcutan
All TauroLock™ lock solutions can cause mild hypocalcaemia (e.g. metallic taste). These mild adverse effects can be avoided by slow instillation respecting the volume of the device or by …See details»
TauroLock Urokinase 25,000 Catheter Lock Solution for Adults
TauroLock products may cause mild hypocalcaemic symptoms (e. g. metallic taste) caused by the contents of 4% citrate if instillation is not done slowly as directed. (ref 3) Storage. Store …See details»
Taurolidine/Citrate Lock Therapy for Primary Prevention of …
Background: Totally implantable venous access port (TIVAP)-related infections (RIs) remain a serious health problem in cancer patients receiving an intravenous (i.v.) therapy. Patients and …See details»
ANTIMICROBIAL CATHETER LOCK SOLUTION - TauroPharm
TauroPharm GmbH August-Bebel-Str. 51 D-97297 Waldbüttelbrunn Tel.: +49 (0) 931 304 299-0 ISO 13485 0123 WWW.TAUROLOCK.COM 85101/47/19 Indication: TauroLock™ is approved …See details»
TauroLock™ - taurolidine based lock solutions effective and safe
Jun 2, 2020 TauroLock™ - ANTIMICROBIAL CATHETER LOCK SOLUTIONTauroLock™ is approved to be instilled into catheter-based devicesfor central venous access in order to mai...See details»
The efficacy of taurolidine containing lock solutions for the ...
Aug 5, 2021 The incidence of central venous catheter (CVC)-related bloodstream infections is high in patients requiring a long-term CVC. Therefore, infection prevention is of the utmost …See details»
FAQ about our lock solutions | TauroLock™ - TauroPharm
In addition to taurolidine and 4 % citrate, TauroLock™-HEP100 contains 100 IU/ml heparin to improve patency. TauroLock™-HEP-500 contains 500 IU/ml heparin.. Тhe most effective …See details»
Taurolidine-Citrate-Heparin the superior lock solution - Transcutan
The utilisation of TauroLock™-Hep500 as an antimicrobial lock solution in dialysis has shown a signifi cant reduction of catheter related bloodstream infections (CRBSI) in many different …See details»
TauroLock™ – à propos du produit
Nous recommandons TauroLock™ pour tous les dispositifs d'accès vasculaire (DAV) en nutrition parentérale, en oncologie et – comme alternative à TauroLock™-HEP500 ou TauroLock™ …See details»